The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top company in the healthcare industry, investors are treating Pfizer as a ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Pfizer is expected to post earnings of $0.67 ...

Pfizer, under the leadership of Albert Bourla, remains under pressure from critics, pessimists, and others, which is not surprising since its stock price is near multi-year lows, and Oxbryta ...

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the ...

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is ...

Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...

Since that time, though, demand for these products has declined, and that's resulted in lower revenue and a drop in the Pfizer share price. Right now, as an investor, you may be wondering if you ...